| Literature DB >> 28555926 |
Fong-Lin Chen1,2, Yung-Po Liaw3,4, Shu-Yi Hsu3, Oswald Ndi Nfor3.
Abstract
BACKGROUND: Chronic tracheal obstruction has been associated with learning deficits; hence, early surgical intervention has been suggested. AIM: To evaluate the relationship between learning performance and vascular ring caused by an isolated aberrant right subclavian artery.Entities:
Keywords: learning performance; public health; tracheal compression; vascular rings
Mesh:
Year: 2017 PMID: 28555926 PMCID: PMC5655769 DOI: 10.1002/jcu.22502
Source DB: PubMed Journal: J Clin Ultrasound ISSN: 0091-2751 Impact factor: 0.910
Figure 1(A) Suprasternal echocardiographic view showing isolated right subclavian artery (ARSCA) separated from the left common carotid artery (LCCA). (B) Lateral view of barium esophagogram revealing compression in the posterior wall of the esophagus (arrow).
Prevalence Rates of Vascular Ring Based on Gender
| VR | No VR | Prevalence (%) | |
|---|---|---|---|
| Total | 21 | 1,664 | 1.26 |
| College of Medicine | 4 | 827 | 0.48 |
| Other colleges | 17 | 837 | 2.03 |
| Male | |||
| College of Medicine | 1 | 550 | 0.18 |
| Other colleges | 8 | 389 | 2.06 |
| Female | |||
| College of Medicine | 3 | 277 | 1.07 |
| Other colleges | 9 | 448 | 2.01 |
Abbreviation: VR, vascular ring.
Odd Ratio (OR) for Vascular Ring Among Low‐ (Other Colleges) and High‐Performing (College of Medicine) Students
| OR | 95% CI | ||
|---|---|---|---|
|
| |||
| Learning performance | |||
| Medicine (college) | ref | ||
| Other colleges | 4.20 | 1.41 | 12.53 |
|
| |||
| Learning performance | |||
| Medicine (college) | ref | ||
| Other colleges | 3.95 | 1.30 | 11.95 |
| Gender | |||
| Male | ref | ||
| Female | 1.37 | 0.57 | 3.30 |
Abbreviations: OR, odd ratio; CI, confidence interval
Odds ratio (OR) of Vascular Ring in Low‐ and High‐Performing Students Using Multiple Logistic Regression Analysis
| OR | 95%CI | ||
|---|---|---|---|
| Learning Performance | |||
| College of Medicine | ref | ||
| Other colleges | 4.90 | 1.30 | 18.40 |
| Gender | |||
| Male | ref | ||
| Female | 0.52 | 0.06 | 4.80 |
| Age | |||
| <19 | ref | ||
| ≥19 | 0.08 | 0.02 | 0.42 |
| BUN (mg/dl) | |||
| <10 | ref | ||
| 10–12 | 0.14 | 0.02 | 0.89 |
| 12–14 | 0.74 | 0.17 | 3.12 |
| >14 | 0.77 | 0.16 | 3.65 |
| SBP (mm Hg) | |||
| <110 | ref | ||
| 110–120 | 0.88 | 0.18 | 4.21 |
| 120–129 | 1.44 | 0.28 | 7.36 |
| >129 | 0.62 | 0.07 | 5.87 |
| DBP (mm Hg) | |||
| <68 | ref | ||
| 68–75 | 2.13 | 0.45 | 10.06 |
| 75–80 | 0.61 | 0.07 | 5.56 |
| >80 | 1.29 | 0.25 | 6.57 |
| Hb (g/dl) | |||
| <13.6 | ref | ||
| 13.6–14.8 | 0.73 | 0.09 | 5.68 |
| 14.8–15.9 | 1.23 | 0.09 | 16.60 |
| >15.9 | 3.22 | 0.11 | 99.25 |
| Ht (%) | |||
| <41.5 | ref | ||
| 41.5–44.9 | 2.28 | 0.29 | 17.98 |
| 44.9–47.6 | 0.65 | 0.03 | 13.35 |
| >47.6 | 0.07 | 0.00 | 4.17 |
| WBC (cells/mm3) | |||
| <5,590 | ref | ||
| 5,590–6,470 | 0.94 | 0.18 | 4.84 |
| 6,470–7,510 | 1.87 | 0.40 | 8.66 |
| >7,510 | 1.96 | 0.36 | 10.69 |
| RBC (106cells/mm3) | |||
| <4.64 | ref | ||
| 4.64–511 | 0.45 | 0.08 | 2.56 |
| 5.11–541 | 0.56 | 0.05 | 6.58 |
| >5.41 | 1.64 | 0.13 | 21.37 |
| MCV (fl) | |||
| <87.2 | ref | ||
| 87.2–89.8 | 0.53 | 0.10 | 2.80 |
| 89.8–92.2 | 0.63 | 0.10 | 4.01 |
| >92.2 | 0.47 | 0.06 | 3.80 |
| Platelet (109/l) | |||
| <230 | ref | ||
| 230–263 | 2.31 | 0.47 | 11.31 |
| 263–299 | 1.03 | 0.21 | 5.07 |
| >299 | 0.50 | 0.08 | 3.03 |
| AST (IU/l) | |||
| <15 | ref | ||
| 15–17 | 0.86 | 0.13 | 5.73 |
| 17–20 | 1.59 | 0.28 | 9.14 |
| >20 | 1.30 | 0.16 | 10.87 |
| ALT (Ul) | |||
| <10 | ref | ||
| 10–14 | 9.68 | 1.58 | 59.23 |
| 14–20 | 2.51 | 0.30 | 21.00 |
| >20 | 3.64 | 0.32 | 41.17 |
| ALP (U/l) | |||
| <59 | ref | ||
| 59–71 | 0.30 | 0.06 | 1.53 |
| 71–86 | 0.70 | 0.16 | 2.98 |
| >86 | 0.55 | 0.10 | 2.91 |
| ALB (g/dl) | |||
| <4.7 | ref | ||
| 4.7–4.9 | 0.57 | 0.10 | 3.33 |
| 4.9–5 | 0.11 | 0.01 | 1.72 |
| >5 | 1.98 | 0.39 | 9.98 |
| TB (mg/dl) | |||
| <0.8 | ref | ||
| 0.8–1.0 | 1.07 | 0.19 | 5.94 |
| 1.0–1.3 | 1.32 | 0.27 | 6.40 |
| >1.3 | 1.18 | 0.22 | 6.23 |
| LDH (U/l) | |||
| <171 | ref | ||
| 171–356 | 1.09 | 0.20 | 6.09 |
| 356–513 | 0.64 | 0.10 | 4.18 |
| >513 | 1.80 | 0.32 | 10.11 |
| CHO (mg/dl) | |||
| <151 | ref | ||
| 151–170 | 0.99 | 0.24 | 4.13 |
| 170–190 | 0.15 | 0.02 | 1.06 |
| >190 | 0.77 | 0.16 | 3.58 |
| CRE (mg/dl) | |||
| <0.8 | ref | ||
| 0.8–0.9 | 0.31 | 0.04 | 2.29 |
| 0.9–1.0 | 2.21 | 0.43 | 11.36 |
| >1.0 | 0.59 | 0.07 | 5.09 |
| UA (mg/dl) | |||
| <4.8 | ref | ||
| 4.8–5.8 | 0.62 | 0.14 | 2.73 |
| 5.8–6.9 | 0.13 | 0.02 | 1.13 |
| >6.9 | 0.29 | 0.04 | 2.16 |
Abbreviations: Ref, reference level; BUN, blood urea nitrogen; SBP, systolic blood pressure; DBP, diastolic blood pressure; Hb, hemoglobin level; Ht, hematocrit; WBC, white blood cells count; RBC, red blood cells count; MCV, mean corpuscular volume; platelet, platelet count; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; ALB, albumin; TB, total bilirubin; LDH, lactate dehydrogenase; CHO, total cholesterol; CRE, creatinine; UA, uric acid.